Accexible
PrivateLast Round
Accelerator
Oct 1, 2024
Total Funding Raised
$1.27M
Company Overview
Accexible operates in Healthcare & Life Sciences and is based in Bilbao. Its latest recorded funding round was an Accelerator round in October 2024.
Accexible is a healthtech company that has developed a speech analysis platform for the early detection and monitoring of mental health conditions like dementia and mild cognitive impairment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Telemedicine, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Government Contracts
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accexible Comparables
Compare Accexible with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LangAware | 87% | |
| Zana Technologies | 84% | |
| Voinosis | 81% |
For institutional investors. Book with your work email.
Accexible Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 1, 2024 | ||||
| Seed | Mar 1, 2023 | ||||
| Accelerator | Mar 21, 2022 | ||||
| Seed | Jan 1, 2021 | ||||
| Accelerator | Sep 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Accexible Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Santalucía Impulsa | Accelerator |
| PharmStars | Accelerator |
| EIT Health | Seed |
| Center for Technological Development and Innovation | Grant |
| BIND 4.0 | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2024
Received funding from Santalucía Impulsa.
- Aug 27, 2024
Grew 23% QoQ, from 13 to 16 employees.
For institutional investors. Book with your work email.
Accexible Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Accexible's valuation, stock price, and market status.
Is Accexible a public or private company?
Accexible is a private company.
What is the current stock price of Accexible?
Accexible is a private company, so its shares have no public market price. Caplight tracks Accexible's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Accexible worth (valuation)?
Valuation information for Accexible is not publicly available.
Can I buy Accexible stock?
Accexible shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Accexible's last funding round?
Accexible's most recent funding round was Accelerator on October 1, 2024.
Who are the main investors in Accexible?
Key investors in Accexible include Santalucía Impulsa, PharmStars, EIT Health, Center for Technological Development and Innovation, BIND 4.0.
Will Accexible IPO soon?
No public IPO plans have been announced for Accexible.
How can I track Accexible secondary market activity?
Caplight tracks bids, offers, and trades in Accexible's shares on secondary markets.